Historic Boston Globe editorial on FDA, stem cells & patients argues safety first

Stem-Cell-Medicine

For the first time I have ever seen in at least half a dozen years, a major newspaper in the form of The Boston Globe has published an editorial on FDA regulation of stem cells. The editorial, entitled “It should be safety-first on stem cell therapies”, argues that while we should take patient concerns into …

Historic Boston Globe editorial on FDA, stem cells & patients argues safety first Read More »